THE PROGNOSTIC SIGNIFICANCE OF MYC AND BCL2 PROTEIN DOUBLE EXPRESSION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, NOS, IN THE ABSENCE OF MYC REARRANGEMENT

被引：0
|
作者：
Fraenza, C. [1 ]
Bernasconi, R. [1 ]
Parisi, A. [1 ]
Tisi, M. C.
Riva, M. [2 ]
Moretta, F. [3 ]
Brighenti, A. [3 ]
Ferrarini, I. [1 ]
Tanasi, I. [1 ]
Quaglia, F. M. [1 ]
Krampera, M. [1 ]
Visco, C. [1 ]
机构：
[1] Univ Studi Verona, Verona, Italy
[2] Osped San Bortolo, Bortolo, Italy
[3] IRCSS Ospedale Sacro Cuore Don Calabria, Calabria, Italy
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P48
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [1] MYC Cytogenetic Status Correlates With Expression and Has Prognostic Significance in Patients With MYC/BCL2 Protein Double-positive Diffuse Large B-cell Lymphoma
    Wang, Xuan Julia
    Medeiros, L. Jeffrey
    Lin, Pei
    Yin, C. Cameron
    Hu, Shimin
    Thompson, Mary Ann
    Li, Shaoying
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (09) : 1250 - 1258
  • [2] Prognostic Significance of Double Expression of C-MYC and BCL2 in Diffuse Large B Cell Lymphoma
    Rashed, Hayam
    Abdelrahman, Aziza Elsayed
    Ismail, Eman
    Obaya, Ahmed
    Abdelhamid, Mohamed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S360 - S360
  • [3] MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B-cell lymphoma patients
    Wang, Yanjie
    Liu, Donglin
    Zhang, Xudong
    Zhang, Mingzhi
    Li, Shenglei
    Feng, Xiaoyan
    Dong, Meng
    Ma, Shanshan
    Qian, Siyu
    Wang, Zeyuan
    Zhang, Yue
    Wang, Pengyuan
    Mei, Shuhao
    Chen, Qingjiang
    CANCER MEDICINE, 2023, 12 (18): : 18568 - 18577
  • [4] Interpreting MYC and BCL2 in diffuse large B-cell lymphoma
    Lai, Catherine
    Grant, Cliona
    Dunleavy, Kieron
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2091 - 2092
  • [5] Myc rearrangement and concurrent high protein expression of C-Myc/Bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma
    Wang, Xingyu
    He, Juan
    He, Hong
    Shuai, Yuhan
    Wang, Lixin
    Li, Yuanxin
    Huang, Ying
    Yu, Kuai
    Zhao, Min
    Xie, Tao
    Li, Dan
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 66
  • [6] The significance of concurrent MYC and BCL2 expression in Egyptian patients with diffuse large B-cell NHL
    Abdelhamid, Thoraya M.
    Gaber, Ayman A.
    Abdelfattah, Raafat M.
    Algamal, Dina A.
    Hamdy, Omar
    Mohamed, Ghada
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
  • [7] MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab
    Perry, Anamarija M.
    Alvarado-Bernal, Yuridia
    Laurini, Javier A.
    Smith, Lynette M.
    Slack, Graham W.
    Tan, King L.
    Sehn, Laurie H.
    Fu, Kai
    Aoun, Patricia
    Greiner, Timothy C.
    Chan, Wing C.
    Bierman, Philip J.
    Bociek, Robert G.
    Armitage, James O.
    Vose, Julie M.
    Gascoyne, Randy D.
    Weisenburger, Dennis D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (03) : 382 - 391
  • [8] MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma
    Xu, Jie
    Liu, Jing-Lan
    Medeiros, L. Jeffrey
    Huang, Wenting
    Khoury, Joseph D.
    McDonnell, Timothy J.
    Tang, Guilin
    Schlette, Ellen
    Yin, C. Cameron
    Bueso-Ramos, Carlos E.
    Lin, Pei
    Li, Shaoying
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (04) : 336 - 343
  • [9] Prognostic outcomes of diffuse large B-cell lymphoma patients with myelocytomatosis oncogene (MYC) and B-cell lymphoma 2 (BCL2) co-expression
    Supanut Kumjan
    Kantang Satayasoontorn
    Kasidid Lawongsa
    Chonlada Laoruangroj
    Journal of Hematopathology, 2025, 18 (1)
  • [10] BCL2 and MYC Protein Expression in Primary Testicular Diffuse Large B Cell Lymphoma
    Gascoyne, R. D.
    Tan, K. L.
    Ben-Neriah, S.
    Savage, K. J.
    Telio, D.
    Hung, T.
    Connors, J. M.
    Scott, D. W.
    Steidl, C.
    Slack, G. W.
    MODERN PATHOLOGY, 2012, 25 : 336A - 336A
12345